Literature DB >> 21265797

Discovering new clinical markers in the field of glycomics.

Jayne E Telford1, Margaret A Doherty, Tharmala Tharmalingam, Pauline M Rudd.   

Abstract

Glycosylation modifications have been reported in a number of disease states and, as a result, there is significant focus on the discovery and development of glycan-based biomarkers. Glyco-biomarkers have the potential to enhance the efficacy and efficiency of the diagnostic procedures for these diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21265797     DOI: 10.1042/BST0390327

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  5 in total

1.  Priming mass spectrometry-based sulfoglycomic mapping for identification of terminal sulfated lacdiNAc glycotope.

Authors:  Shin-Yi Yu; Lan-Yi Chang; Chu-Wen Cheng; Chi-Chi Chou; Michiko N Fukuda; Kay-Hooi Khoo
Journal:  Glycoconj J       Date:  2012-06-01       Impact factor: 2.916

2.  Evaluation of riproximin binding properties reveals a novel mechanism for cellular targeting.

Authors:  Helene Bayer; Katharina Essig; Sven Stanzel; Martin Frank; Jeffrey C Gildersleeve; Martin R Berger; Cristina Voss
Journal:  J Biol Chem       Date:  2012-08-07       Impact factor: 5.157

3.  The diagnostic value of serum DSA-TRF in hepatocellular carcinoma.

Authors:  Wenqian Guan; Zhiyuan Gao; Chenjun Huang; Meng Fang; Huijuan Feng; Shipeng Chen; Mengmeng Wang; Jun Zhou; Song Hong; Chunfang Gao
Journal:  Glycoconj J       Date:  2020-01-13       Impact factor: 2.916

4.  Human urinary glycoproteomics; attachment site specific analysis of N- and O-linked glycosylations by CID and ECD.

Authors:  Adnan Halim; Jonas Nilsson; Ulla Rüetschi; Camilla Hesse; Göran Larson
Journal:  Mol Cell Proteomics       Date:  2011-12-14       Impact factor: 5.911

5.  An engineered high affinity Fbs1 carbohydrate binding protein for selective capture of N-glycans and N-glycopeptides.

Authors:  Minyong Chen; Xiaofeng Shi; Rebecca M Duke; Cristian I Ruse; Nan Dai; Christopher H Taron; James C Samuelson
Journal:  Nat Commun       Date:  2017-05-23       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.